NeuroBo Pharmaceuticals (NRBO) Misses Q3 EPS by 55c

NeuroBo Pharmaceuticals (NASDAQ: NRBO) reported Q3 EPS of ($0.55).

For earnings history and earnings-related data on NeuroBo Pharmaceuticals (NRBO) click here.

You May Also Be Interested In

• Robinhood Ventures Fund II opens at $22.50, IPO at $25
• Ideal Power (IPWR) Tops Q2 EPS by 2c
• Brinker Int'l (EAT) PT Raised to $285 at UBS Following 'Impressive' Q4 Outperformance